These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 19340432)
1. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome. Watanabe T; Vital A; Nobusawa S; Kleihues P; Ohgaki H Acta Neuropathol; 2009 Jun; 117(6):653-6. PubMed ID: 19340432 [TBL] [Abstract][Full Text] [Related]
2. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337 [TBL] [Abstract][Full Text] [Related]
3. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related]
4. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Bendig I; Mohr N; Kramer F; Weber BH Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368 [TBL] [Abstract][Full Text] [Related]
7. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
8. [Germline mutations of the p53 gene]. Frebourg T Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948 [TBL] [Abstract][Full Text] [Related]
9. Three germline mutations in the TP53 gene. Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the IDH1 codon 132 mutation in brain tumors. Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363 [TBL] [Abstract][Full Text] [Related]
11. High frequency of de novo mutations in Li-Fraumeni syndrome. Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618 [TBL] [Abstract][Full Text] [Related]
12. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T; J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570 [TBL] [Abstract][Full Text] [Related]
13. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
14. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816 [TBL] [Abstract][Full Text] [Related]
15. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844 [TBL] [Abstract][Full Text] [Related]
17. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma. Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503 [TBL] [Abstract][Full Text] [Related]
18. IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival. Thon N; Eigenbrod S; Kreth S; Lutz J; Tonn JC; Kretzschmar H; Peraud A; Kreth FW Cancer; 2012 Jan; 118(2):452-60. PubMed ID: 21717448 [TBL] [Abstract][Full Text] [Related]
19. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Krutilkova V; Trkova M; Fleitz J; Gregor V; Novotna K; Krepelova A; Sumerauer D; Kodet R; Siruckova S; Plevova P; Bendova S; Hedvicakova P; Foreman NK; Sedlacek Z Eur J Cancer; 2005 Jul; 41(11):1597-603. PubMed ID: 15925506 [TBL] [Abstract][Full Text] [Related]
20. The Li-Fraumeni syndrome: an inherited susceptibility to cancer. Evans SC; Lozano G Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]